GlassScriptPhysician profile
Aparna Vuppala
NPI 1538200605
$2,725.52
in general payments reported to CMS, 2019-2025
16 companies · $487 in 2025
The $487 reported for 2025 was more than what 75% of Child & Adolescent Psychiatry providers received nationally (typical 2025 total: $132).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $227 · 2020: $70.96 · 2021: $82.76 · 2022: $620 · 2023: $439 · 2024: $799 · 2025: $487.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,712 · Education: $12.69.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,712.36 |
| Education | $12.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $1,461.99 | 2021-2025 | Qelbree, Qelbree |
| Ironshore Pharmaceuticals INC. | $275.80 | 2019-2024 | Jornay Pm |
| Tris Pharma INC | $222.88 | 2019-2025 | Dyanavel Xr |
| Corium, LLC | $210.52 | 2022-2025 | Azstarys |
| Neurocrine Biosciences, INC. | $122.87 | 2025 | |
| Allergan, INC. | $94.11 | 2019 | |
| Neos Therapeutics, LP | $66.67 | 2019-2024 | Adzenys Xr-Odt |
| Collegium Pharmaceutical, INC. | $55.26 | 2025 | Jornay Pm |
| Janssen Pharmaceuticals, INC | $54.69 | 2019-2022 | |
| Adlon Therapeutics L.P. | $54.60 | 2019-2021 | |
| Vertical Pharmaceuticals, LLC | $26.44 | 2024 | Relexxii |
| Alkermes, INC. | $21.29 | 2022 | |
| Alfasigma USA, INC. | $18.12 | 2022 | |
| Noven Therapeutics, LLC | $17.23 | 2024 | Xelstrym |
| Shire North American Group INC | $11.70 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $11.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aparna Vuppala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.